Rock Springs Capital Management LP Mirati Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $12.4 Million - $18.4 Million	-295,431 Reduced 26.12%	835,776 $49.1 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $265,768 - $433,546	9,560 Added 0.85%	1,131,207 $49.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $2.04 Million - $2.79 Million	56,386 Added 5.29%	1,121,647 $40.5 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $9.51 Million - $14.1 Million	260,237 Added 32.33%	1,065,261 $39.6 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $2.55 Million - $6.09 Million	-61,752 Reduced 7.12%	805,024 $36.5 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $1.3 Million - $1.89 Million	21,799 Added 2.58%	866,776 $60.5 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $11.2 Million - $25.3 Million	285,243 Added 50.96%	844,977 $56.7 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $11.3 Million - $22.5 Million	149,319 Added 36.38%	559,734 $46 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $7.51 Million - $10.8 Million	56,901 Added 16.1%	410,415 $60.2 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $4.55 Million - $6.11 Million	34,429 Added 10.79%	353,514 $62.5 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $656,928 - $819,928	-4,562 Reduced 1.41%	319,085 $51.5 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $7.87 Million - $11 Million	-49,505 Reduced 13.27%	323,647 $55.4 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $3.95 Million - $5.86 Million	24,391 Added 6.99%	373,152 $82 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $522,864 - $874,151	7,261 Added 2.13%	348,761 $39.8 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $2.9 Million - $4.82 Million	41,500 Added 13.83%	341,500 $26.3 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $3.01 Million - $5.48 Million	42,500 Added 16.5%	300,000 $38.7 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $4.29 Million - $6.03 Million	55,000 Added 27.16%	257,500 $20.1 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $1.34 Million - $2.36 Million	22,500 Added 12.5%	202,500 $20.9 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $1.31 Million - $2.37 Million	30,000 Added 20.0%	180,000 $13.2 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $2.88 Million - $4.27 Million	-90,000 Reduced 37.5%	150,000 $6.36 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $1.33 Million - $2.67 Million	51,000 Added 26.98%	240,000 $11.8 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $154,800 - $314,550	9,000 Added 5.0%	189,000 $5.8 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $2.28 Million - $3.42 Million	180,000	180,000 $3.29 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account